SOURCE: Visunex Medical Systems

Visunex Medical Logo

April 01, 2016 18:43 ET

Visunex Medical Systems Receives CE Marking for the PanoCam LT System

Revolutionary Imaging Device -- a Completely Wireless Hardware and Software Solution for Imaging All Newborns

FREMONT, CA--(Marketwired - April 01, 2016) -  Visunex Medical Systems, Inc. today announced that it has received CE Mark for the PANOCAM LT Wide-field Imaging System. PanoCam LT is a compact, wireless imaging system that is designed to detect a number of external, anterior, and posterior segment vision disorders in premature and newborn babies. It can also be used for general ophthalmic imaging and eye disease inspection in children up to 6 years old.

"Obtaining the CE mark for PanoCam LT is an important milestone for Visunex, as it allows the commercialization of this product in the European Union and several other countries," stated Dr. Wei Su, CEO of Visunex Medical Systems. The CE mark indicates that the system has met all the requirements of the European Medical Devices Directive, including safety and performance. Clinicians in countries requiring CE Mark now have access to the world's first completely wireless hardware, software and telemedicine solution for identifying vision disorders in newborns.

Each year an estimated 130 million babies are born globally. At birth, newborns are subject to a number of mandatory tests which include hearing screening and bilirubin testing. Although vision screening is not currently provided as a standard of care in most neonatal centers, recent clinical data suggests that vision disorders may affect between 10 and 20 percent of all newborns. Early research conducted in Asia, Brazil and the United States suggests that 1 in 70 children born may have some form of vision disorder.

While many visual problems may be transient, a growing number of clinicians believe that screening newborns may provide early detection of vision disorders such as retinal hemorrhages, which may be a precursor to amblyopia. This serious affliction may have long-term effects on vision and can even permanently impair vision throughout adulthood. Early detection of retinal hemorrhages as well as many other disorders can lead to early therapeutic intervention, which may prevent vision loss.

About the Company: Visunex Medical Systems is a pioneer in developing the most advanced technology and information systems for preserving the vision of children around the world. Our products maximize quality and efficiency in the flow of ocular images and patient data. Based in Fremont, California, the company continues to innovate and deliver superior products and services to enhance global vision. For more information, please visit

Contact Information